Core Alternative Capital’s Bio-Techne TECH Stock Holding History

Core Alternative Capital’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4	Closed	-$297	–	463
2023 Q1	$297	Buy	+4	New	+$308	﹤0.01%	469

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Core Alternative Capital's TECH Position: Q2 2023 in Review

Core Alternative Capital sold out of Bio-Techne (TECH) in Q2 2023, closing a stake of 4 shares — an estimated $297 sold.

Core Alternative Capital first reported a position in TECH in Q1 2023 and held it in 1 quarter. The position peaked at $297 in Q1 2023. 528 funds tracked by Wall St. Rank hold TECH as of Q2 2023.

Core Alternative Capital reported no remaining Bio-Techne position as of Q2 2023 after selling out during the quarter.
Core Alternative Capital sold 4 Bio-Techne shares in Q2 2023, an estimated $297.
Core Alternative Capital first reported a position in Bio-Techne in Q1 2023 and held it in 1 quarter.
Core Alternative Capital's Bio-Techne position peaked at $297 in Q1 2023.
528 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2023.

Based on Core Alternative Capital's 13F filing for Q2 2023, filed 27 Jul 2023.